Regeneron buying 23andMe
Digest more
Top News
Overview
Impacts
Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.
Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA data.
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.
RALEIGH, N.C. (WITN) - The deadline to file claims against a DNA testing company has been announced. In October 2023, 23andMe suffered a massive data breach that potentially compromised the private genetic information of millions of people.